Sandy Spring Bank Regeneron Pharmaceuticals, Inc. Transaction History

Sandy Spring Bank

$2.42 Billion
Q4 2024

A detailed history of Sandy Spring Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sandy Spring Bank holds 63 shares of REGN stock, worth $42,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 63 -0.0%

Holding current value

$42,012

Previous $66,000 33.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$1024.09 - $1201.76 $3,072 - $3,605	-3 Reduced 4.55%	63 $66,000
Q2 2024 Aug 06, 2024	SELL	$883.2 - $1071.19 $27,379 - $33,206	-31 Reduced 31.96%	66 $69,000
Q1 2024 May 08, 2024	BUY	$902.69 - $993.35 $29,788 - $32,780	33 Added 51.56%	97 $93,000
Q4 2023 Jan 26, 2024	SELL	$775.18 - $881.7 $136,431 - $155,179	-176 Reduced 73.33%	64 $56,000
Q2 2023 Aug 04, 2023	BUY	$700.03 - $830.35 $700 - $830	1 Added 0.42%	240 $172,000
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $122,118 - $132,585	173 Added 262.12%	239 $172,000
Q3 2022 Nov 02, 2022	BUY	$573.97 - $724.32 $1,147 - $1,448	2 Added 3.13%	66 $45,000
Q2 2022 Jul 21, 2022	BUY	$548.35 - $738.84 $1,096 - $1,477	2 Added 3.23%	64 $37,000
Q2 2021 Aug 09, 2021	BUY	$472.8 - $558.54 $23,640 - $27,927	50 Added 416.67%	62 $34,000
Q1 2021 May 03, 2021	SELL	$446.73 - $548.2 $1,786 - $2,192	-4 Reduced 25.0%	12 $5,000
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $1,973 - $2,575	4 Added 33.33%	16 $9,000
Q1 2020 May 01, 2020	BUY	$336.18 - $494.43 $4,034 - $5,933	12 New	12 $6,000
Q2 2018 Aug 03, 2018	SELL	$284.6 - $344.99 $9,107 - $11,039	-32 Closed	0 $0
Q1 2018 May 04, 2018	SELL	$315.82 - $393.78 $31,582 - $39,378	-100 Reduced 75.76%	32 $11,000
Q4 2017 Feb 02, 2018	BUY	$358.63 - $469.95 $11,476 - $15,038	32 Added 32.0%	132 $50,000
Q2 2017 Aug 11, 2017	BUY	N/A	100	100 $49,000

Others Institutions Holding REGN

# of Institutions

1,494

Shares Held

85.9M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $71.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Account

Sandy Spring Bank Regeneron Pharmaceuticals, Inc. Transaction History